Healthy lifestyle devotion index as a possible indicator of more severe course of novel coronavirus infection and long-term recovery

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Understanding factors influencing the clinical condition of patients after COVID-19, depending on the level of devotion to the principles of a healthy lifestyle (HLS), can make an additional contribution to improving approaches to the management of patients at the outpatient stage.

The aim: to evaluate healthy lifestyle devotion in patients after COVID-19.

Material and methods. 122 outpatients having had COVID-19 were included in the study. Devotion to a healthy lifestyle was assessed using the integral index of healthy lifestyle devotion (HLSI).

Results. 41,8% of patients aged 43 (28,5; 49,5) years had satisfactory HLSI, 58,2% of patients aged 47 (37; 53) years had unsatisfactory one. Comparatively with persons with unsatisfactory HLSI, satisfactory HLSI was more often recorded in females (p=0,043), younger age (p=0,017), with a lower body mass index (p <0,001), lower incidence of obesity (p <0,001), diabetes mellitus (p=0,04) and arterial hypertension (p=0,021). The probabiluty of a more severe course of the disease with an unsatisfactory HLSI was 2,93 (95% CI: 1,48–5,93), and the risk of hospitalization for COVID-19 was 4 times higher (95% CI: 2,16–7,7) regarding persons with satisfactory HLSI.

Conclusion. The importance of following the principles of a healthy lifestyle for COVID-19 has been confirmed. That can prevent or slow down the progression of the disease, development of complications and speed up the recovery process.

Full Text

Restricted Access

About the authors

Vera N. Larina

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

Author for correspondence.
Email: larinav@mail.ru
ORCID iD: 0000-0001-7825-5597
SPIN-code: 3674-9620

MD, Professor, Head of the Department of Polyclinic Therapy of the Faculty of General Medicine

Russian Federation, Moscow

Alina A. Ryzhikh

N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia

Email: lina.alinamedic@yandex.ru
ORCID iD: 0000-0002-0673-5775
SPIN-code: 4302-3217

Postgraduate Student of the Department of Polyclinic Therapy of the Faculty of General Medicine

Russian Federation, Moscow

References

  1. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. Published: 18 December 2020. Last updated: 11 November 2021. URL: https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742 (date of access – 01.11.2023).
  2. NHS England. National commissioning guidance for post COVID services. Version 3, July 2022. URL: https://www.england.nhs.uk/wp-content/uploads/2022/07/C1670_National-commissioning-guidance-for-post-COVID-services_V3_July-2022-1.pdf (date of access – 01.11.2023).
  3. Crook H., Raza S., Nowell J. et al. Long covid-mechanisms, risk factors, and management [published correction appears in BMJ. 2021; 374: n1944]. BMJ. 2021; 374: n1648. https://dx.doi.org/10.1136/bmj.n1648.
  4. Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes [published correction appears in Nat Med. 2022; 28(8): 1723]. Nat Med. 2022; 28(5): 911–23. https://dx.doi.org/10.1038/s41591-022-01810-6.
  5. D’Anneo A., Lauricella M. Multimodal strategies to fight obesity: research on tailored therapies based on natural and synthetic compounds for prevention, management and treatment. Int J Mol Sci. 2023; 24(12): 10105. https://dx.doi.org/10.3390/ijms241210105.
  6. Longo M., Zatterale F., Naderi J. et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019; 20(9): 2358. https://dx.doi.org/10.3390/ijms20092358.
  7. Mraz M., Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014; 222(3): R113–27. https://dx.doi.org/10.1530/JOE-14-0283.
  8. Hamer M., Kivimaki M., Gale C.R., Batty G.D. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020; 87: 184–87. https://dx.doi.org/10.1016/j.bbi.2020.05.059.
  9. Минздрав России. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 9 (26.10.2020). Доступ: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/052/548/original/МР_COVID-19_%28v.9%29.pdf (дата обращения – 01.11.2023). [Ministry of Healthcare of Russia. Interim guidelines «Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)». Version 9 (10/26/2020). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/052/548/original/МР_COVID-19_%28v.9%29.pdf (date of access – 01.11.2023) (In Russ.)].
  10. World Health Organization. Healthy living: What is a healthy lifestyle? URL: http://apps.who.int/iris/handle/10665/108180 (date of access – 01.11.2023).
  11. Шальнова С.А., Баланова Ю.А., Деев А.Д. с соавт. Интегральная оценка приверженности здоровому образу жизни как способ мониторинга эффективности профилактических мер. Профилактическая медицина. 2018; 21(4): 65–72. [Shalnova S.A., Balanova Yu.A., Deev A.D. et al. Integrated assessment of adherence to a healthy lifestyle as a way of monitoring the effectiveness of preventive measures. Profilakticheskaya meditsina = The Russian Journal of Preventive Medicine. 2018; 21(4): 65–72 (In Russ.)]. https://dx.doi.org/10.17116/profmed201821465. EDN: XWPIZN.
  12. Бубнова М.Г., Аронов Д.М., Бойцов С.А. Методические рекомендации. Обеспечение физической активности у граждан, имеющих ограничения в состоянии здоровья. М.: Государственный научно-исследовательский центр профилактической медицины. 2015; 95 с. [Bubnova M.G., Aronov D.M., Boytsov S.A. Guidelines. Providing physical activity for citizens with health limitations. Moscow: State Research Center for Preventive Medicine. 2015; 95 pp. (In Russ.)]. EDN: VTLUAX.
  13. Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г. с соавт. Международный регистр «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (AКТИВ SARS-CoV-2)»: анализ 1000 пациентов. Российский кардиологический журнал. 2020; 25(11): 98–107. [Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al. International register «Dynamics analysis of comorbidities in SARS-CoV-2 survivors» (AKTIV SARS-CoV-2): analysis of 1,000 patients. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 25(11): 98–107 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2020-4165. EDN: ATQSNN.
  14. Simonnet A., Chetboun M., Poissy J. et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity. 2020; 28(7): 1195–99. https://dx.doi.org/10.1002/oby.22831.
  15. Petrilli C.M., Jones S.A., Yang J. et al. Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City. medRxiv. 2020: 2020.04.08.20057794. https://dx.doi.org/10.1101/2020.04.08.20057794. Preprint.
  16. Глыбочко П.В., Фомин В.В., Авдеев С.Н. с соавт. Клиническая характеристика 1007 больных тяжелой SARS-CoV-2 пневмонией, нуждавшихся в респираторной поддержке. Клиническая фармакология и терапия. 2020; 29(2): 21–29. [Glybochko P.V., Fomin V.V., Avdeev S.N. et al. Clinical characteristics of 1007 intensive care unit patients with SARS-CoV-2 pneumonia. Klinicheskaya farmakologiya i terapiya = Clinical Pharmacology and Therapy. 2020; 29(2): 21–29 (In Russ.)]. https://dx.doi.org/10.32756/0869-5490-2020-2-21-29. EDN: ZWGGBS.
  17. Harris E. High blood pressure more likely after COVID-19 than flu. JAMA. 2023; 330(12): 1127. https://dx.doi.org/10.1001/jama.2023.16676.
  18. Mefford M.T., Wei R., Lustigova E. et al. Incidence of diabetes among youth before and during the COVID-19 pandemic. JAMA Netw Open. 2023; 6(9): e2334953. https://dx.doi.org/10.1001/jamanetworkopen.2023.34953.
  19. Антонов Н.С., Сахарова Г.М. Эффективность применения безрецептурных препаратов для лечения табачной зависимости: обзор литературы. РМЖ. Медицинское обозрение. 2016; 24(12): 804–810. [Antonov N.S., Sakharova G.M. The effectiveness of over-the-counter drugs for the treatment of tobacco dependence: A review of the literature. Russkiy meditsinskiy zhurnal. Meditsinskoye obozreniye = Russian Medical Journal. Medical Review. 2016; 24(12): 804–810 (In Russ.)]. EDN: WHKNQV.
  20. West R., Zatonski W., Cedzynska M. et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med. 2011; 365(13): 1193–200. https://dx.doi.org/10.1056/NEJMoa1102035.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Distribution of the studied patients by gender depending on the index of adherence to a healthy lifestyle

Download (67KB)
Indexing metadata
3. Fig. 2. Distribution of the studied patients by age depending on the index of adherence to a healthy lifestyle

Download (145KB)
Indexing metadata
4. Fig. 3. Distribution of the studied patients by body mass index depending on the index of adherence to a healthy lifestyle

Download (158KB)
Indexing metadata
5. Fig. 4. Frequency of obesity in the groups of studied patients depending on the index of adherence to a healthy lifestyle

Download (82KB)
Indexing metadata

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies